# CHRISTUS Spohn Hospital Corpus Christi-South – FDA Inspection, Oct 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/christus-spohn-hospital-corpus-christi-south/8319c78f-1adb-4733-823e-55afc5cacc2f
Source feed: FDA_Inspections

> FDA inspection 1031298 of CHRISTUS Spohn Hospital Corpus Christi-South, October 17, 2017. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031298
- Company Name: CHRISTUS Spohn Hospital Corpus Christi-South
- Inspection Date: 2017-10-17
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 988965 - 2016-09-23
- FDA Inspection 891824 - 2014-08-20
- FDA Inspection 767978 - 2012-02-06

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/darla-j-christopher/64d3f47f-f3c0-4cfd-a3e8-4dc0e69d04bd)

Company: https://www.keypedia.com/companies/christus-spohn-hospital-corpus-christi-south/64dd4079-527c-4669-8fa1-63a75648be82

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d